India eases medical-device rules on sterilisation, testing fees and EU clinical waivers
The Health Ministry has amended the Medical Devices Rules, 2017 to allow outsourced sterilisation, standardise laboratory testing fees and recognise the EU for certain clinical-investigation waivers—potentially reducing compliance friction and speeding market access for eligible manufacturers and importers.
What happened
retail-company · India’s Health Ministry amended medical-device rules to ease outsourced sterilisation, standardise laboratory testing fees and recognise the EU
Key facts
- Medical Devices Rules, 2017
- three key reform areas
- Rule 63
- Ninth Schedule
- five previously recognised jurisdictions
Why this matters
Strategic buyers should assess Indian device, sterilisation and testing-platform targets that gain scale advantages as regulatory friction falls and market entry accelerates.
What to watch
- Publication of detailed eligibility criteria and implementation guidance for EU clinical-investigation waivers.
- Approval-time data from CDSCO for devices using the amended pathways.
- Growth in applications from EU-based manufacturers and Indian import-license holders.
- Accreditation capacity and pricing of third-party sterilisation providers.
- Tender pricing and import volumes in high-volume consumable and diagnostic-device categories.
- Any quality, recall, or adverse-event scrutiny that prompts tighter enforcement despite the easing.
- Medical-device importers should identify EU-approved products that may qualify for clinical-investigation waivers and prepare prioritized India submission pipelines.
- Domestic manufacturers should assess whether third-party sterilisation partners can replace or defer in-house sterilisation investments.
- Pharmacy, hospital-supply, and diagnostic distributors should revisit category sourcing plans for faster-moving imported devices and consumables.
- Suppliers should benchmark the newly standardized testing fees against current approval and quality-control costs before repricing tenders or distributor contracts.
- Large healthcare retailers should seek preferred-launch or exclusive-distribution arrangements with overseas manufacturers entering India.